Cited by 1,704Immune Response and InflammationNF-κB Signaling PathwaysTuberculosis Research and Epidemiology

Peptidoglycan- and Lipoteichoic Acid-induced Cell Activation Is Mediated by Toll-like Receptor 2

Open access
Schwandner, Ralf, Dziarski, Roman, Wesche, Holger, Rothe, Mike, Kirschning, Carsten J.·1999·Journal of Biological Chemistry

Abstract

The life-threatening complications of sepsis in humans are elicited by infection with Gram-negative as well as Gram-positive bacteria. Recently, lipopolysaccharide (LPS), a major biologically active agent of Gram-negative bacteria, was shown to mediate cellular activation by a member of the human Toll-like receptor family, Toll-like receptor (TLR) 2. Here we investigate the mechanism of cellular activation by soluble peptidoglycan (sPGN) and lipoteichoic acid (LTA), main stimulatory components of Gram-positive bacteria. Like LPS, sPGN and LTA bind to the glycosylphosphatidylinositol-anchored membrane protein CD14 and induce activation of the transcription factor NF-kappaB in host cells like macrophages. We show that whole Gram-positive bacteria, sPGN and LTA induce the activation of NF-kappaB in HEK293 cells expressing TLR2 but not in cells expressing TLR1 or TLR4. The sPGN- and LTA-induced NF-kappaB activation was not inhibited by polymyxin B, an antibiotic that binds and neutralizes LPS. Coexpression together with membrane CD14 enhances sPGN signal transmission through TLR2. In contrast to LPS signaling, activation of TLR2 by sPGN and LTA does not require serum. These findings identify TLR2 as a signal transducer for sPGN and LTA in addition to LPS.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1074/jbc.274.25.17406

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. De Kimpe, S. J., Kengatharan, M., Thiemermann, C., and Vane, J. R. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 10359 -10363
  2. Rock, F. L., Hardiman, G., Timans, J. C., Kastelein, R. A., and Bazan, J. F. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 588 -593

Cited by

Sorted by citations

Authors
Schwandner, R., Dziarski, R., Wesche, H., Rothe, M., & Kirschning, C. J.
Affiliations
Indiana University School of Medicine (US)
Corresponding author
Kirschning, Carsten J.
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
1999-06
Volume
274
Issue
25
Pages
17406-17409
ISSN
0021-9258 (ISSN-L)
OpenAlex
W2008152503
Cited by
1,704
References
39
Citations by year
2026: 21 · 2025: 14 · 2024: 20 · 2023: 25 · 2022: 31 · 2021: 45 · 2020: 21 · 2019: 43 · 2018: 39 · 2017: 40 · 2016: 51 · 2015: 26 · 2014: 51 · 2013: 74 · 2012: 59
FWCI
33.87
Type
journal article
Language
en
Open access
Locations
  • Journal of Biological Chemistry (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health
  • National Institute of Allergy and Infectious Diseases (AI-28797, R01AI028797)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
  • Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
Keywords
TLR2, peptidoglycan, lipoteichoic acid, Gram-positive bacteria, CD14, NF-κB activation, macrophage activation, sepsis, lipopolysaccharide, polymyxin B, TLR1, TLR4, bacterial cell wall recognition
MeSH terms
Cell Line, Gram-Negative Bacteria, Gram-Positive Bacteria, Humans, Lipopolysaccharides, Membrane Glycoproteins, Peptidoglycan, Polymyxin B, Receptors, Cell Surface, Teichoic Acids, Signal Transduction, Transcriptional Activation, NF-kappa B, Glycosylphosphatidylinositols, Lipopolysaccharide Receptors, Drosophila Proteins, Toll-Like Receptors, Toll-Like Receptor 1, Toll-Like Receptor 2, Toll-Like Receptor 4

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review